The conundrum of opioid tapering in long-term opioid therapy for chronic pain: A commentary

REFERENCES

• Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain – United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.
   PubMed Web of Science ®Google Scholar
• Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Opioid use behaviors, mental health and pain–development of a typology of chronic pain patients. Drug and alcohol dependence. 2009;104(1–2):34–42.
   PubMed Web of Science ®Google Scholar
• Von Korff MR, Franklin G. Responding to America's Iatrogenic Epidemic of Prescription Opioid Addiction and Overdose. Med Care. 2016;54(5):426–429.
   PubMed Web of Science ®Google Scholar
• Weimer MB, Hartung DM, Ahmed S, Nicolaidis C. A chronic opioid therapy dose reduction policy in primary care. Substance abuse: official publication of the Association for Medical Education and Research in Substance Abuse. 2016;37(1):141–147.
   PubMed Web of Science ®Google Scholar
• Weeks WB. Hailey. JAMA. 2016;316(19):1975–1976.
   PubMed Web of Science ®Google Scholar
• Riley JL, Wade JB. Psychological and Demographic Factors that Modulate the Different Stages and Dimensions of Pain. In: Price DD, Bushnell MC, eds. Psychological methods of pain control: basic science and clinical perspectives. Seattle, WA: IASP Press; 2004.
   Google Scholar
• Leknes S, Brooks JC, Wiech K, Tracey I. Pain relief as an opponent process: a psychophysical investigation. Eur J Neurosci. 2008;28(4):794–801.
   PubMed Web of Science ®Google Scholar
• Seymour B, O'Doherty JP, Koltzenburg M, et al. Opponent appetitive-aversive neural processes underlie predictive learning of pain relief. Nature neuroscience. 2005;8(9):1234–1240.
   PubMed Web of Science ®Google Scholar
• Leknes S, Berna C, Lee MC, Snyder GD, Biele G, Tracey I. The importance of context: when relative relief renders pain pleasant. Pain. 2013;154(3):402–410.
   PubMed Web of Science ®Google Scholar
• Franklin JC, Puzia ME, Lee KM, et al. The Nature of Pain Offset Relief in Nonsuicidal Self-Injury: A Laboratory Study. Clinical Psychological Science. 2013;1(2):110–119.
   Google Scholar
• Navratilova E, Morimura K, Xie JY, Atcherley CW, Ossipov MH, Porreca F. Positive emotions and brain reward circuits in chronic pain. J Comp Neurol. 2016.
   PubMed Web of Science ®Google Scholar
• Zubieta JK. Pain signal as threat and reward. Neuron. 2010;66(1):6–7.
   PubMed Web of Science ®Google Scholar
• Fields HL. Understanding how opioids contribute to reward and analgesia. Reg Anesth Pain Med. 2007;32(3):242–246.
   PubMed Web of Science ®Google Scholar
• Navratilova E, Porreca F. Reward and motivation in pain and pain relief. Nat Neurosci. 2014;17(10):1304–1312.
   PubMed Web of Science ®Google Scholar
• Baker TB, Tiffany ST. Morphine-Tolerance as Habituation. Psychol Rev. 1985;92(1):78–108.
   PubMed Web of Science ®Google Scholar
• Howe CQ, Sullivan MD. The missing ‘P’ in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care. Gen Hosp Psychiatry. 2014;36(1):99–104.
   PubMed Web of Science ®Google Scholar
• Lee MC, Wanigasekera V, Tracey I. Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain. Neuropharmacology. 2014;84:123–130.
   PubMed Web of Science ®Google Scholar
• Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nature reviews Neuroscience. 2001;2(10):695–703.
   PubMed Web of Science ®Google Scholar
• Meyer PJ, King CP, Ferrario CR. Motivational Processes Underlying Substance Abuse Disorder. Current topics in behavioral neurosciences. 2015.
   Google Scholar
• Ballantyne JC, Sullivan MD, Kolodny A. Opioid Dependence vs Addiction: A Distinction Without a Difference? Archives of internal medicine. 2012;172(17):1342–1343.
   PubMedGoogle Scholar
• Koob GF, Le Moal M. Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2008;363(1507):3113–3123.
   PubMed Web of Science ®Google Scholar
• Koob GF, Stinus L, Le Moal M, Bloom FE. Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neuroscience and biobehavioral reviews. 1989;13(2–3):135–140.
   PubMed Web of Science ®Google Scholar
• Le Moal M, Koob GF. Drug addiction: pathways to the disease and pathophysiological perspectives. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. 2007;17(6–7):377–393.
   PubMed Web of Science ®Google Scholar
• Ballantyne JC. Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain. Pain. 2015;156(4):567–568.
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR Recommendations and Reports. 2016;65(1):1–49.
   PubMed Web of Science ®Google Scholar
• Lembke A. Why doctors prescribe opioids to known opioid abusers. The New England journal of medicine. 2012;367(17):1580–1581.
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Suzan E, Pud D. Opioid-induced hyperalgesia (OIH): a real clinical problem or just an experimental phenomenon? J Pain Symptom Manage. 2015;49(3):632–636.
   PubMed Web of Science ®Google Scholar
• Yi P, Pryzbylkowski P. Opioid Induced Hyperalgesia. Pain medicine (Malden, Mass). 2015;16 Suppl 1:S32–36.
   PubMedGoogle Scholar
• Bespalov A, Muller R, Relo AL, Hudzik T. Drug Tolerance: A Known Unknown in Translational Neuroscience. Trends in pharmacological sciences. 2016.
   PubMed Web of Science ®Google Scholar
• Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. The Clinical journal of pain. 2008;24(6):469–478.
   PubMed Web of Science ®Google Scholar
• Raffa RB, Pergolizzi JV, Jr. Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients? Pain Manag Nurs. 2013;14(3):e67–83.
   PubMedGoogle Scholar
• Volkow ND, McLellan AT. Opioid Abuse in Chronic Pain–Misconceptions and Mitigation Strategies. The New England journal of medicine. 2016;374(13):1253–1263.
   PubMed Web of Science ®Google Scholar
• Miguez G, Laborda MA, Miller RR. Classical conditioning and pain: conditioned analgesia and hyperalgesia. Acta Psychol (Amst). 2014;145:10–20.
   PubMed Web of Science ®Google Scholar
• Kalant H. Research on tolerance: What can we learn from history? Alcoholism-Clinical and Experimental Research. 1998;22(1):67–76.
   PubMed Web of Science ®Google Scholar
• Satel SL, Kosten TR, Schuckit MA, Fischman MW. Should protracted withdrawal from drugs be included in DSM-IV? The American journal of psychiatry. 1993;150(5):695–704.
   PubMed Web of Science ®Google Scholar
• Heilig M, Egli M, Crabbe JC, Becker HC. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addiction biology. 2010;15(2):169–184.
   PubMed Web of Science ®Google Scholar
• Solomon RL. The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am Psychol. 1980;35(8):691–712.
   PubMed Web of Science ®Google Scholar
• Shurman J, Koob GF, Gutstein HB. Opioids, Pain, the Brain, and Hyperkatifeia: A Framework for the Rational Use of Opioids for Pain. Pain Medicine. 2010;11(7):1092–1098.
   PubMed Web of Science ®Google Scholar
• White JM. Pleasure into pain: the consequences of long-term opioid use. Addictive behaviors. 2004;29(7):1311–1324.
   PubMed Web of Science ®Google Scholar
• Arout CA, Edens E, Petrakis IL, Sofuoglu M. Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations. CNS drugs. 2015;29(6):465–486.
   PubMed Web of Science ®Google Scholar
• Koob GF, Buck CL, Cohen A, et al. Addiction as a stress surfeit disorder. Neuropharmacology. 2014;76 Pt B:370–382.
   PubMedGoogle Scholar
• Ballantyne JC, Stannard C. New addiction criteria: diagnostic challenges persist in treating pain with opioids. Pain. 2013;1.
   Google Scholar
• SAMHSA. Protracted withdrawal. Substance abuse treatment advisory. 2010;9(1):1–8.
   Google Scholar
• Kertesz SG. Turning the tide or riptide? The changing opioid epidemic. Substance abuse: official publication of the Association for Medical Education and Research in Substance Abuse. 2017;38(1):3–8.
   PubMed Web of Science ®Google Scholar
• Berland DW, Malinoff HL, Weiner MA, Przybylski R. When Opioids Fail in Chronic Pain Management: The Role for Buprenorphine and Hospitalization. American Journal of Therapeutics. 2013;20(4):316–321.
   PubMed Web of Science ®Google Scholar
• Butler S. Buprenorphine—Clinically useful but often misunderstood. Scandinavian Journal of Pain. 2013;4(3):148–152.
   PubMedGoogle Scholar
• Foster B, Twycross R, Mihalyo M, Wilcock A. Buprenorphine. J Pain Symptom Manage. 2013;45(5):939–949.
   PubMed Web of Science ®Google Scholar
• Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage. 2005;29(3):297–326.
   PubMed Web of Science ®Google Scholar
• Rhodin A, Gronbladh L, Nilsson LH, Gordh T. Methadone treatment of chronic non-malignant pain and opioid dependence–a long-term follow-up. Eur J Pain. 2006;10(3):271–278.
   PubMed Web of Science ®Google Scholar
• Neumann AM, Blondell RD, Jaanimagi U, et al. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction. J Addict Dis. 2013;32(1):68–78.
   PubMed Web of Science ®Google Scholar
• Heit HA, Covington E, Good PM. Dear DEA. Pain medicine (Malden, Mass). 2004;5(3):303–308.
   PubMed Web of Science ®Google Scholar
• Center for Substance Abuse T. SAMHSA/CSAT Treatment Improvement Protocols. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004.
   Google Scholar
• VA/DoD Clinical Practive Guideleine Management of Opioid Therapy for Chronic pain. The Management of Opioid Therapy for Chronic Pain Working Group;2010.
   Google Scholar
• Blondell RD, Ashrafioun L, Dambra CM, Foschio EM, Zielinski AL, Salcedo DM. A Clinical Trial Comparing Tapering Doses of Buprenorphine with Steady Doses for Chronic Pain and Co-existent Opioid Addiction. Journal of addiction medicine. 2010;4(3):140–146.
   PubMed Web of Science ®Google Scholar
• Berna C, Kulich RJ, Rathmell JP. Tapering Long-term Opioid Therapy in Chronic Noncancer Pain: Evidence and Recommendations for Everyday Practice. Mayo Clin Proc. 2015;90(6):828–842.
   PubMed Web of Science ®Google Scholar